[Clinical experiences in the use of intravenously injectable tetanus-immune human gamma globulin TIG(i). II. Clinical and side effects (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D013742:Tetanus / Q000517:prevention & control / Q000628:therapy*; D013743:Tetanus Antitoxin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014947:Wounds and Injuries / Q000150:complications; D005719:gamma-Globulins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D013743:Tetanus Antitoxin; D005719:gamma-Globulins